Glycated albumin as a diagnostic tool for diabetes in a general Japanese population

Metabolism: Clinical and Experimental

Volumn 64, Issue 6, 2015, Pages 698-705

  Ikezaki, Hiroaki ^a,b   Furusyo, Norihiro ^a   Ihara, Takeshi ^a   Hayashi, Takeo ^a   Ura, Kazuya ^a   Hiramine, Satoshi ^a   Mitsumoto, Fujiko ^a   Takayama, Koji ^a   Murata, Masayuki ^a   Kohzuma, Takuji ^c   Ai, Masumi ^d   Schaefer, Ernst J ^b   Hayashi, Jun ^a,e  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b TUFTS UNIVERSITY   (United States)

^c Asahi Kasei Pharma   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY HOSPITAL   (Japan)

^e Hara Doi Hospital   (Japan)

Author keywords

Diabetes; Glycated albumin; Oral glucose tolerance test

Indexed keywords

GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED SERUM ALBUMIN; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ANALYSIS; ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CARDIOVASCULAR DISEASES; GLUCOSE TOLERANCE TEST; MIDDLE AGED; REFERENCE VALUE; RISK FACTOR; YOUNG ADULT;

ADULT; AGED; ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; SERUM ALBUMIN; YOUNG ADULT;

EID: 84927970888     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.03.003     Document Type: Article

References (36)

1. D.R. Whiting, L. Guariguata, C. Weil, and J. Shaw IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030 Diabetes Res Clin Pract 94 2011 311 321
2. The DECODE study group Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of diagnostic criteria in Europe Lancet 354 1999 617 621
3. M. Tominaga, H. Eguchi, H. Manaka, K. Igarashi, T. Kato, and A. Sekikawa Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study Diabetes Care 22 1999 920 924
4. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, and E.A. Walker Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
5. J.L. Chiasson, R.G. Josse, R. Gomis, M. Hanefeld, A. Karasik, and M. Laakso STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial Lancet 359 2002 2072 2077
6. J.P. Foo, and C.S. Mantzoros The quest for the perfect biomarker of long-term glycemia: new studies, new trials and tributions Metabolism 60 2011 1651 1654
7. World Health Organization (WHO) Report of a World Health Organization Consultation: use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus Diabetes Res Clin Pract 93 2011 299 309
8. C. Kim, K.M. Bullard, W.H. Herman, and G.L. Beckles Association between iron deficiency and A1c levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006 Diabetes Care 33 2010 780 785
9. E.S. Ford, C.C. Cowie, C. Li, Y. Handelsman, and Z.T. Bloomgarden Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US J Diabetes 3 2011 67 73
10. Y. Tahara, and K. Shima Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level Diabetes Care 18 1995 440 447
11. S. Takahashi, H. Uchino, T. Shimizu, A. Kanazawa, Y. Tamura, and K. Sakai Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control Endocr J 54 2007 139 144
12. H. Ogata, K. Tokuyama, S. Nagasaka, T. Tsuchita, I. Kusaka, and S. Ishibashi The lack of long-range negative correlations in glucose dynamics is associated with worse glucose control in patients with diabetes mellitus Metabolism 61 2012 1041 1050
13. T. Suwa, A. Ohta, T. Matsui, R. Koganei, H. Kato, and T. Kawata Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM) Endocr J 57 2010 135 140
14. N. Furusyo, and J. Hayashi Glycated albumin and diabetes mellitus Biochim Biophys Acta 2013 1830 5509 5514
15. H. Nagayama, M. Inaba, R. Okabe, M. Emoto, E. Ishimura, and S. Okazaki Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test Biomed Pharmacother 63 2009 236 240
16. S. Yamada, M. Inaba, S. Okada, Y. Imanishi, K. Mori, and M. Emoto Association of glycated albumin, but not glycated hemoglobin, with calcaneus quantitative ultrasound in male hemodialysis patients with type 2 diabetes mellitus Metabolism 59 2010 390 394
17. M.P. Cohen, E. Hud, E. Shea, and C.W. Shearman Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice Metabolism 51 2002 901 905
18. T. Kohzuma, and M. Koga Lucica GA-L glycated albumin assay kit: a new diagnostic test for diabetes mellitus Mol Diagn Ther 14 2010 49 51
19. N. Furusyo, T. Koga, M. Ai, S. Otokozawa, T. Kohzuma, and H. Ikezaki Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS) Diabetologia 54 2011 3028 3036
20. N. Furusyo, T. Koga, M. Ai, S. Otokozawa, T. Kohzuma, and H. Ikezaki Plasma glycated albumin level and atherosclerosis: Results from the Kyushu and Okinawa Population Study (KOPS) Int J Cardiol 167 2013 2066 2072
21. K. Norimatsu, S. Miura, Y. Suematsu, Y. Shiga, Y. Miyase, and A. Nakamura Associations between glycated albumin or hemoglobin A1c and the presence of coronary artery disease J Cardiol 2014 10.1016/j.jjcc.2014.07.006 [in press]
22. L.J. Pu, L. Lu, W.F. Shen, Q. Zhang, R.Y. Zhang, and J.S. Zhang Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetes patients Circ J 71 2007 1067 1073
23. E. Selvin, L.M. Francic, C.M. Ballantyne, R.C. Hoogeveen, J. Coresh, and F.L. Brancati Nontraditional markers of glycemia: associations with microvascular conditions Diabetes Care 34 2011 960 967
24. S. Matsuo, E. Imai, M. Horio, Y. Yasuda, K. Tomita, and K. Nitta Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 2009 982 992
25. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
26. W.G. John, M.R. Gray, D.L. Bates, and J.L. Beacham Enzyme immunoassay: a new technique for estimating hemoglobin A1c Clin Chem 39 1993 663 666
27. I. Goodall, P.G. Colman, H.G. Schneider, M. McLean, and G. Baker Desirable performance standards for HbA(1c) analysis - precision, accuracy and standardization: consensus statement of the Australasian Association of Clinical biochemists (AACCB), the Australian diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA) Clin Chem Lab Med 45 2007 1083 1097
28. E.R. Delong, D.M. Delong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
29. D.M. Nathan, M.W. Steffes, W. Sun, G.P. Rynders, and J.M. Lachin Determining stability of stored samples retrospectively: the validation of glycated albumin Clin Chem 57 2011 286 290
30. J. Baraka-Vidot, A. Guerin-Dubourg, F. Dubois, B. Payet, E. Bourdon, and P. Rondeau New insights into deleterious impacts of in vivo glycation on albumin antioxidant activities Biochim Biophys Acta 2013 1830 3532 3541
31. M.P. Cohen, K. Sharma, Y. Jin, E. Hud, V.Y. Wu, and J. Tomaszewski Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy J Clin Invest 95 1995 2338 2345
32. V.Y. Wu, and M.P. Cohen Evidence for a ligand receptor system mediating the biologic effects of glycated albumin in glomerular mesangial cells Biochem Biophys Res Commun 207 1995 521 528
33. S.P. Juraschek, M.W. Steffes, E.R. Miller III, and E. Selvin Alternative markers of hyperglycemia and risk of diabetes Diabetes Care 35 2012 2265 2270
34. The DECODE-DECODA Study Group on behalf of the European Diabetes Epidemiology Group, and The International Diabetes Epidemiology Group Age, body mass index and type 2 diabetes - associations modified by ethnicity Diabetologia 46 2003 1063 1070
35. A. Taniguchi, Y. Nakai, M. Fukushima, H. Kawamura, H. Imura, and I. Nagata Pathogenic factors responsible for glucose intolerance in patients with NIDDM Diabetes 41 1992 1540 1546
36. E. Selvin, M.W. Steffes, C.M. Ballantyne, R.C. Hoogeveen, J. Coresh, and F.L. Brancati Racial differences in glycemic markers: a cross-sectional analysis of community-based data Ann Intern Med 154 2011 303 309